This week, we speak to Dr. William Soliman, Chairman and CEO, of the Accreditation Council for Medical Affairs, about establishing industry benchmarks, what it is like to join the field now, and what it means to be a futurist in medical affairs.
This special topical episode is focused and dedicated to patients around the world who are suffering with a rare disorder or rare disease.
In this episode, Anne opens the show defining rare disease. A rare disease is a condition that affects fewer than 200,000 people, whereas Europe defines it as something that affects less than 1 in 2,000 people. Drug companies have not been interested in developing treatments for rare diseases; there just wasn’t the incentive. The drug companies would not be able to sustain the costs involved in developing medicine.
This month’s guest is Dr. William Soliman. Will is the founder of The ACMA, the first and only global accreditation council for medical affairs professionals, he is also a seasoned media figure and thought leader in the biotech industry, with several years of leadership experience in the Pharma industry under his belt. Will has been instrumental in launching a variety of innovative platforms and expanding the role of medical affairs across the industry.
In this episode, Anne opens the show describing some future focused trends in the medical affairs field. She and Will speak on controversial drug pricing issues – such as, what does the election year mean for the industry from an innovation perspective? There is no doubt that we want to make drugs as affordable for as many people. However, the challenge comes in when a majority of the clinical trials fail. The solution to drug pricing may be thinking about more efficient and effective ways to design clinical trials. Machine learning and AI can come into play for a clinical trial designer. The V3 team discusses here.
In this episode, MPL founders Jeff Pike, Ben Penley, and Smit Patel sit down together to conduct their first Q&A w/ listeners.
Millennial Pharma Leader is an online magazine and podcast focused on careers in the pharmaceutical industry. As we learned about the huge variety of opportunities in this field, we were surprised that there really weren’t a lot of resources teaching students and starting professionals how to get involved. With a team of talented authors, we have worked hard to bring regular content by millennials, for millennials. Our goal is to share the stories of our most successful peers and mentors. Hopefully these stories, interviews, and topic discussions will be informative and help you paint a better picture of the opportunities for ambitious new professionals in the drug development sector.
William Soliman, PhD, BCMAS President of the ACMA & Senior Level Life Sciences & Pharmaceutical Industry Expert delivers the latest news & updates from the Accreditation Council for Medical Affairs (ACMA).
Welcome to the inaugural episode of The V3 Podcast, launching Tuesday, July 2, 2019. The V3 Podcast will showcase the vision, the voice and the value of Medical Affairs. Biopharma industry executive veteran, Dr. Anne Arvizu, will interview like-minded leaders and key global strategists who will share their knowledge, insights and new cutting-edge information. This higher-level look, at what keeps your patients first in our industry, will help you to position the role of medical affairs as the key driver for your organization and the Biopharma world moving forward. This is the Future of Medical Affairs.
This show is being produced by the Pharmacy Podcast Network and is parter-sponsored by The Accreditation Council for Medical Affairs (ACMA) to help better serve the next generation of medical affairs leadership and adding value by supporting the medical experts and compliance leaders in our industry. You can find out more about ACMA here